We are live on ! Find out more
PIP

Palisades Investment Partners Portfolio holdings

AUM $352M
1-Year Est. Return 76.79%
This Fund
S&P 500
This Quarter Est. Return
+5.2%
1 Year Est. Return
+76.79%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$265M
AUM Growth
+$10M
Cap. Flow
+$9.07M
Cap. Flow %
3.43%
Top 10 Hldgs %
47.51%
Holding
53
New
4
Increased
43
Reduced
2
Closed
2

Top Buys

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$4.48M
2
EEFT icon
Euronet Worldwide
EEFT
+$1.23M
3
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$751K
4
PKE icon
Park Aerospace
PKE
+$628K
5
STRL icon
Sterling Infrastructure
STRL
+$587K

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$2.16M
2
CCRD
CoreCard
CCRD
+$1.35M
3
MPTI.WS
M-tron Industries Warrants
MPTI.WS
+$115K
4
BMI icon
Badger Meter
BMI
+$43.4K

Sector Composition

Rank Sector Weight
1 Industrials 35.98%
2 Healthcare 22.92%
3 Technology 18.12%
4 Financials 13.93%
5 Consumer Discretionary 3.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARDX icon
51
Ardelyx
ARDX
$1.01B
$59.2K 0.02%
10,147
– –
CCRD
52
DELISTED
CoreCard
CCRD
– –
-50,329
Closed -$1.35M
MPTI.WS
53
DELISTED
M-tron Industries Warrants
MPTI.WS
– –
-65,856
Closed -$115K
1 2
3

Similar funds

ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
AW
Alaethes Wealth Glenbrook, Nevada $351M AUM 22.79% 1-Year Est. Return
EC
Elmind Capital New York $352M AUM
BL
BCWM LLC Overland Park, Kansas $353M AUM 20.1% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
EPW
Endeavor Private Wealth Topeka, Kansas $349M AUM 16.45% 1-Year Est. Return
NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return

Palisades Investment Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Palisades Investment Partners held 53 positions worth $265M, up 3.9% from $255M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Palisades Investment Partners deployed $9.07M of net new capital in Q4 2025, opening 4 new positions and adding to 43 existing holdings. Its largest new stake was Travere Therapeutics: 137,768 shares worth $5.26M.

By sector, the portfolio is most concentrated in Industrials at 36% of assets, down from 38% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $2.16M trimmed.

  • Palisades Investment Partners's largest Q4 2025 buy was Travere Therapeutics: 137,768 shares worth $5.26M.
  • Palisades Investment Partners added most to Park Aerospace in Q4 2025, an estimated $628K increase.
  • Palisades Investment Partners's biggest Q4 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $2.16M.
  • Palisades Investment Partners fully exited CoreCard in Q4 2025, selling an estimated $1.35M.
  • Palisades Investment Partners's ten largest holdings make up 48% of its $265M portfolio in Q4 2025.
  • Palisades Investment Partners opened 4 new positions and closed 2 in Q4 2025.
  • Palisades Investment Partners's portfolio value rose 3.9% quarter-over-quarter to $265M.

Based on Palisades Investment Partners's 13F filing for Q4 2025, filed 20 Jan 2026.